Cargando…
Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity
BACKGROUND: The efficacy of a non-prescription drug to support weight loss programs has yet to be compared. This clinical trial investigates the comparability of orlistat 60 milligram (mg) and polyglucosamine. METHODS: Sixty-four overweight or obese subjects were included in a two-center double-blin...
Autores principales: | Stoll, Manfred, Bitterlich, Norman, Cornelli, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225614/ https://www.ncbi.nlm.nih.gov/pubmed/28097013 http://dx.doi.org/10.1186/s40608-016-0130-4 |
Ejemplares similares
-
Efficacy of polyglucosamine for weight loss—confirmed in a randomized double-blind, placebo-controlled clinical investigation
por: Pokhis, Karina, et al.
Publicado: (2015) -
Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction
por: Cornelli, Umberto, et al.
Publicado: (2017) -
Effect of Polyglucosamine on Weight Loss and Metabolic Parameters in Overweight and Obesity: A Systematic Review and Meta-Analysis
por: Perna, Simone, et al.
Publicado: (2020) -
A Randomized Double-Blind Placebo-Controlled Clinical Study to Evaluate the Effect on the Weight of a Medical Device with Polyglucosamine L112 in a Group of Overweight and Obese Subjects
por: Rondanelli, Mariangela, et al.
Publicado: (2023) -
Estradiol: micrograms or milligrams
por: Kirk, Jeremy M W, et al.
Publicado: (2016)